Insider · CIK 0001549936

Marth William S

Reports to the SEC for 3 companies · ALBANY, NY

sec.gov

Transactions

Companies

Filings

CIK

0001549936

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-21	Teligent, Inc.Restricted Stock UnitsA Award	Director	AAward	+150K sh	—	—	150,000
2021-02-16	Teligent, Inc.Stock OptionA Award	Director	AAward	+2,000 sh	—	—	2,000
2017-08-31	ALBANY MOLECULAR RESEARCH INCJ Other	Director, President and CEO	JOther	−18.5K sh	—	—	503,416
2017-08-31	ALBANY MOLECULAR RESEARCH INCJ Other	Director, President and CEO	JOther	−20.4K sh	—	—	483,033
2017-08-31	ALBANY MOLECULAR RESEARCH INCD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−483K sh	$21.75	−$10.5M	0
2017-08-31	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−54.5K sh	$5.98	−$326K	0
2017-08-31	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−134K sh	$3.34	−$447K	0
2017-07-05	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+884 sh	$16.04	+$14.2K	521,888
2017-02-08	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+27.2K sh	—	—	500,621
2017-02-08	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+20.4K sh	—	—	521,004
2017-02-08	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockA Award	Director, President and CEO	AAward	+134K sh	—	—	133,690
2017-02-04	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−41.6K sh	$18.52	−$771K	475,404
2017-02-04	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−1,942 sh	$18.52	−$36K	473,462
2017-01-01	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−8,425 sh	$18.63	−$157K	517,030
2016-07-11	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+49K sh	—	—	182,000
2016-07-05	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+1,312 sh	$11.42	+$15K	525,455
2016-05-16	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+12.5K sh	$12.86	+$161K	524,143
2016-02-04	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+71.3K sh	$15.77	+$1.13M	510,178
2016-02-04	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockA Award	Director, President and CEO	AAward	+54.5K sh	$15.77	+$859K	54,498
2016-01-06	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+490 sh	$16.79	+$8,227.1	510,668
2016-01-01	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−8,374 sh	$20.16	−$169K	438,840
2015-07-06	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+975 sh	$13.34	+$13K	511,643
2015-06-04	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+10K sh	$19.98	+$200K	447,214
2015-06-04	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+58K sh	—	—	133,000
2015-04-07	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	$2.59	+$25.9K	424,847
2015-04-07	ALBANY MOLECULAR RESEARCH INCM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.4K sh	$5.99	+$74.1K	437,214
2015-04-07	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	—	—	0
2015-04-07	ALBANY MOLECULAR RESEARCH INCOption to Purchase Common StockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.4K sh	—	—	0
2015-03-05	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+20K sh	$17.70	+$354K	414,847
2015-03-02	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+58.7K sh	$17.05	+$1M	393,907
2015-01-22	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+940 sh	$13.84	+$13K	394,847
2015-01-01	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−8,443 sh	$16.10	−$136K	335,256
2014-11-10	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+30K sh	$17.01	+$510K	343,699
2014-09-18	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+25K sh	—	—	75,000
2014-02-04	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+95.2K sh	$10.50	+$1M	283,699
2014-01-31	ALBANY MOLECULAR RESEARCH INCF Tax Payment	Director, President and CEO	FTax Payment	−1,905 sh	—	—	188,461
2014-01-23	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+37K sh	—	—	50,000
2014-01-01	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+99.2K sh	$10.08	+$1M	190,366
2013-12-03	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+30K sh	$10.75	+$323K	91,159
2013-11-22	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+20K sh	$11.57	+$231K	61,159
2013-06-05	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+2,868 sh	$10.46	+$30K	41,159
2013-06-03	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+10K sh	$10.23	+$102K	38,291
2013-06-03	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+10K sh	$10.23	+$102K	38,291
2013-01-31	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+5,843 sh	$5.99	+$35K	28,291
2013-01-31	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director, President and CEO	AAward	+12.4K sh	$5.99	+$74.1K	12,367
2012-12-03	ALBANY MOLECULAR RESEARCH INCP Purchase	Director, President and CEO	PPurchase	+10K sh	$5.00	+$50K	22,448
2012-06-13	ALBANY MOLECULAR RESEARCH INCOption to purchase Common StockA Award	Director, President and CEO	AAward	+10K sh	$2.59	+$25.9K	10,000
2012-06-06	ALBANY MOLECULAR RESEARCH INCA Award	Director, President and CEO	AAward	+12.4K sh	$2.41	+$30K	12,448

Recent filings

Accepted (ET)
Jul 224
Marth William S0000352998-21-000010
SEC(opens sec.gov)
Feb 244
Marth William S0001549936-21-000003
SEC(opens sec.gov)
Sep 54
Marth William S0001638599-17-000865
SEC(opens sec.gov)
Jul 64
ALBANY MOLECULAR RESEARCH INC0001638599-17-000687
SEC(opens sec.gov)
Feb 104
ALBANY MOLECULAR RESEARCH INC0001638599-17-000182
SEC(opens sec.gov)
Feb 74
ALBANY MOLECULAR RESEARCH INC0001638599-17-000154
SEC(opens sec.gov)
Jan 34
ALBANY MOLECULAR RESEARCH INC0001638599-17-000004
SEC(opens sec.gov)
Jul 124
Sorrento Therapeutics, Inc.0000899243-16-024988
SEC(opens sec.gov)
Jul 74
ALBANY MOLECULAR RESEARCH INC0001638599-16-001156
SEC(opens sec.gov)
May 164
ALBANY MOLECULAR RESEARCH INC0001638599-16-000878
SEC(opens sec.gov)
Feb 125
ALBANY MOLECULAR RESEARCH INC0001144204-16-081609
SEC(opens sec.gov)
Feb 84
ALBANY MOLECULAR RESEARCH INC0001638599-16-000623
SEC(opens sec.gov)

Companies

Address

21 CORPORATE CIRCLE PO BOX 15098

ALBANY, NY, 12033